Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5476
KLX Energy Services
KLXE
$138M
| $440K | ﹤0.01% |
170,680
-42,459
| -20% | -$126K |
2018 Q3
31 quarters
|
|
5477
PicS N.V.
PICS
$1.71B
| $439K | ﹤0.01% |
41,264
-75,989
| -65% | -$863K |
2026 Q1
1 quarter
|
|
5478
Opendoor Technologies Inc Series K Warrants
OPENW
$1.62M
| $439K | ﹤0.01% |
885,958
+179
| +0% | +$108 |
2025 Q4
2 quarters
|
|
5479
Lumexa Imaging Holdings
LMRI
$1.01B
| $438K | ﹤0.01% |
38,863
-65,567
| -63% | -$598K |
2025 Q4
2 quarters
|
|
5480
Mammoth Energy Services
TUSK
$130M
| $434K | ﹤0.01% |
133,560
-19,163
| -13% | -$56.1K |
2016 Q4
38 quarters
|
|
5481
Pioneer Bancorp
PBFS
$426M
| $434K | ﹤0.01% |
25,428
-1,509
| -6% | -$23K |
2019 Q3
27 quarters
|
|
5482
Galectin Therapeutics
GALT
$367M
| $434K | ﹤0.01% |
93,475
-10,930
| -10% | -$28.3K |
2013 Q3
51 quarters
|
|
5483
BNY Mellon Concentrated Growth ETF
BKCG
$123M
| $433K | ﹤0.01% |
11,617
-467
| -4% | -$17.3K |
2025 Q1
5 quarters
|
|
5484
Faeth Therapeutics
FTH
$517M
| $433K | ﹤0.01% |
17,329
+8,534
| +97% | +$197K |
2021 Q1
21 quarters
|
|
5485
Global X MSCI China Consumer Discretionary ETF
CHIQ
$102M
| $433K | ﹤0.01% |
27,372
-2,492
| -8% | -$47.1K |
2013 Q2
52 quarters
|
|
5486
ALPS Smith Core Plus Bond ETF
SMTH
$3.6B
| $432K | ﹤0.01% |
16,772
-418
| -2% | -$10.8K |
2025 Q3
3 quarters
|
|
5487
Biglari Holdings Class A
BH.A
$1.21B
| $431K | ﹤0.01% |
205
-18
| -8% | -$29.5K |
2018 Q2
32 quarters
|
|
5488
Riverview Bancorp
RVSB
$120M
| $429K | ﹤0.01% |
79,023
-14,877
| -16% | -$82.3K |
2013 Q4
50 quarters
|
|
5489
MacroGenics
MGNX
$211M
| $429K | ﹤0.01% |
92,788
-76,324
| -45% | -$289K |
2013 Q4
50 quarters
|
|
5490
Black Diamond Therapeutics
BDTX
$97.7M
| $428K | ﹤0.01% |
231,200
+142,577
| +161% | +$349K |
2020 Q1
25 quarters
|
|
5491
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$272M
| $426K | ﹤0.01% |
9,254
+645
| +7% | +$28.8K |
2018 Q4
30 quarters
|
|
5492
Global X FTSE Southeast Asia ETF
ASEA
$96.3M
| $425K | ﹤0.01% |
21,664
-11
| -0.1% | -$218 |
2013 Q2
52 quarters
|
|
5493
American Century US Quality Growth ETF
QGRO
$1.96B
| $425K | ﹤0.01% |
3,596
+1,203
| +50% | +$137K |
2022 Q3
15 quarters
|
|
5494
Syntec Optics
OPTX
$278M
| $424K | ﹤0.01% |
34,078
+31,894
| +1,460% | +$318K |
2025 Q4
2 quarters
|
|
5495
Optimum Communications Inc
OPTU
$335M
| $423K | ﹤0.01% |
291,902
-3,684,280
| -93% | -$4.58M |
2017 Q2
36 quarters
|
|
5496
Dimensional National Municipal Bond ETF
DFNM
$2.21B
| $422K | ﹤0.01% |
8,734
+1
| +0% | +$48 |
2023 Q1
13 quarters
|
|
5497
Sono-Tek
SOTK
$97.6M
| $422K | ﹤0.01% |
68,974
+58,854
| +582% | +$285K |
2022 Q2
16 quarters
|
|
5498
NACCO Industries
NC
$257M
| $422K | ﹤0.01% |
8,425
+323
| +4% | +$16.2K |
2013 Q2
52 quarters
|
|
5499
WisdomTree Artificial Intelligence and Innovation Fund
WTAI
$630M
| $420K | ﹤0.01% |
8,850
+384
| +5% | +$15.2K |
2023 Q4
10 quarters
|
|
5500
Vuzix
VUZI
$185M
| $419K | ﹤0.01% |
144,627
-61,919
| -30% | -$195K |
2015 Q1
45 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.